The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Acute Hemodynamic Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Diastolic Heart Failure (DILATE-1)
Open accessAbstract
BACKGROUND: Deficient nitric oxide-soluble guanylate cyclase-cyclic guanosine monophosphate signaling results from endothelial dysfunction and may underlie impaired cardiac relaxation in patients with heart failure with preserved left ventricular ejection fraction (HFpEF) and pulmonary hypertension (PH). The acute hemodynamic effects of riociguat, a novel soluble guanylate cyclase stimulator, were characterized in patients with PH and HFpEF. METHODS: Clinically stable patients receiving standard HF therapy with a left ventricular ejection fraction > 50%, mean pulmonary artery pressure (mPAP) ≥ 25 mm Hg, and pulmonary arterial wedge pressure (PAWP) > 15 mm Hg at rest were randomized to single oral doses of placebo or riociguat (0.5, 1, or 2 mg). The primary efficacy variable was the peak decrease in mPAP from baseline up to 6 h. Secondary outcomes included hemodynamic and echocardiographic parameters, safety, and pharmacokinetics. RESULTS: There was no significant change in peak decrease in mPAP with riociguat 2 mg (n = 10) vs placebo (n = 11, P = .6). However, riociguat 2 mg significantly increased stroke volume (+9 mL [95% CI, 0.4-17]; P = .04) and decreased systolic BP (-12 mm Hg [95% CI, -22 to -1]; P = .03) and right ventricular end-diastolic area (-5.6 cm2 [95% CI, -11 to -0.3]; P = .04), without significantly changing heart rate, PAWP, transpulmonary pressure gradient, or pulmonary vascular resistance. Riociguat was well tolerated. CONCLUSIONS: In patients with HFpEF and PH, riociguat was well tolerated, had no significant effect on mPAP, and improved exploratory hemodynamic and echocardiographic parameters. TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT01172756; URL: www.clinicaltrials.gov.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs104 · Cited by 6,879
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
Owan, T. E., Hodge, D. O., Herges, R. M., Jacobsen, S. J., Roger, V. L., & Redfield, M. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052256 · Cited by 4,191
Authors/Task Force Members, Galie, N., Hoeper, M. M., Humbert, M., Torbicki, A., Vachiery, J.-L., Barbera, J. A., Beghetti, M., Corris, P., Gaine, S., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp297 · Cited by 3,846
Self-citationRecommendations for chamber quantification☆
LANG, R., BIERIG, M., DEVEREUX, R., FLACHSKAMPF, F., FOSTER, E., PELLIKKA, P., PICARD, M., ROMAN, M., SEWARD, J., & SHANEWISE, J. (2006) · European Journal of Echocardiography · doi:10.1016/j.euje.2005.12.014 · Cited by 3,571
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
Paulus, W. J., & Tschöpe, C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.092 · Cited by 3,564
Zile, M. R., Baicu, C. F., & Gaasch, W. H. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032566 · Cited by 1,563
Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
Ghofrani, H.-A., D'Armini, A. M., Grimminger, F., Hoeper, M. M., Jansa, P., Kim, N. H., Mayer, E., Simonneau, G., Wilkins, M. R., Fritsch, A., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209657 · Cited by 1,401
Self-citationRiociguat for the treatment of pulmonary arterial hypertension
Ghofrani, H.-A., Galiè, N., Grimminger, F., Grünig, E., Humbert, M., Jing, Z.-C., Keogh, A. M., Langleben, D., Kilama, M. O., Fritsch, A., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209655 · Cited by 1,346
Self-citationPulmonary Hypertension in Heart Failure With Preserved Ejection Fraction
Lam, C. S. P., Roger, V. L., Rodeheffer, R. J., Borlaug, B. A., Enders, F. T., & Redfield, M. M. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.051 · Cited by 1,341
Self-citationRedfield, M. M., Chen, H. H., Borlaug, B. A., Semigran, M. J., Lee, K. L., Lewis, G., LeWinter, M. M., Rouleau, J. L., Bull, D. A., Mann, D. L., et al. (2013) · JAMA · doi:10.1001/jama.2013.2024 · Cited by 1,155
Kawaguchi, M., Hay, I., Fetics, B., & Kass, D. A. (2003) · Circulation · doi:10.1161/01.cir.0000048123.22359.a0 · Cited by 934
Global Cardiovascular Reserve Dysfunction in Heart Failure With Preserved Ejection Fraction
Borlaug, B. A., Olson, T. P., Lam, C. S. P., Flood, K. S., Lerman, A., Johnson, B. D., & Redfield, M. M. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.03.077 · Cited by 729
Self-citationSoluble Guanylate Cyclase as an Emerging Therapeutic Target in Cardiopulmonary Disease
Stasch, J.-P., Pacher, P., & Evgenov, O. V. (2011) · Circulation · doi:10.1161/circulationaha.110.981738 · Cited by 601
Guazzi, M., Vicenzi, M., Arena, R., & Guazzi, M. D. (2011) · Circulation · doi:10.1161/circulationaha.110.983866 · Cited by 545
Low Myocardial Protein Kinase G Activity in Heart Failure With Preserved Ejection Fraction
van Heerebeek, L., Hamdani, N., Falcão-Pires, I., Leite-Moreira, A. F., Begieneman, M. P. V., Bronzwaer, J. G. F., van der Velden, J., Stienen, G. J. M., Laarman, G. J., Somsen, A., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.076075 · Cited by 525
Explaining the Phenomenon of Nitrate Tolerance
Münzel, T., Daiber, A., & Mülsch, A. (2005) · Circulation Research · doi:10.1161/01.res.0000184694.03262.6d · Cited by 424
Vascular Endothelial Dysfunction and Mortality Risk in Patients With Chronic Heart Failure
Katz, S. D., Hryniewicz, K., Hriljac, I., Balidemaj, K., Dimayuga, C., Hudaihed, A., & Yasskiy, A. (2005) · Circulation · doi:10.1161/01.cir.0000153349.77489.cf · Cited by 410
Diastolic Pulmonary Vascular Pressure Gradient
Gerges, C., Gerges, M., Lang, M. B., Zhang, Y., Jakowitsch, J., Probst, P., Maurer, G., & Lang, I. M. (2013) · Chest · doi:10.1378/chest.12-1653 · Cited by 368
Self-citationEffects of Vasodilation in Heart Failure With Preserved or Reduced Ejection Fraction
Schwartzenberg, S., Redfield, M. M., From, A. M., Sorajja, P., Nishimura, R. A., & Borlaug, B. A. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.09.062 · Cited by 331
Bonderman, D., Ghio, S., Felix, S. B., Ghofrani, H.-A., Michelakis, E., Mitrovic, V., Oudiz, R. J., Boateng, F., Scalise, A.-V., Roessig, L., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.001458 · Cited by 326
Self-citationAkiyama, E., Sugiyama, S., Matsuzawa, Y., Konishi, M., Suzuki, H., Nozaki, T., Ohba, K., Matsubara, J., Maeda, H., Horibata, Y., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.036 · Cited by 284
Pulmonary Pressures and Death in Heart Failure
Bursi, F., McNallan, S. M., Redfield, M. M., Nkomo, V. T., Lam, C. S. P., Weston, S. A., Jiang, R., & Roger, V. L. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.076 · Cited by 281
Self-citationGrimminger, F., Weimann, G., Frey, R., Voswinckel, R., Thamm, M., Bölkow, D., Weissmann, N., Mück, W., Unger, S., Wensing, G., et al. (2009) · European Respiratory Journal · doi:10.1183/09031936.00039808 · Cited by 249
Self-citationNO-Independent, Haem-Dependent Soluble Guanylate Cyclase Stimulators
Stasch, J.-P., & Hobbs, A. J. (2008) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-540-68964-5_13 · Cited by 205
Gender-specific hypertension and responsiveness to nitric oxide in sGCα1 knockout mice
Buys, E. S., Sips, P. Y., Vermeersch, P., Raher, M. J., Rogge, E., Ichinose, F., Dewerchin, M. A., Bloch, K. D., Janssens, S. P., & Brouckaert, P. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn068 · Cited by 117
Riociguat for the treatment of pulmonary hypertension
SCHERMULY, R. T., Janssen, W., Weißmann, N., Stasch, J., Grimminger, F., & Ghofrani, H. A. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.565048 · Cited by 108
Sharkovska, Y., Kalk, P., Lawrenz, B., Godes, M., Hoffmann, L. S., Wellkisch, K., Geschka, S., Relle, K., Hocher, B., & Stasch, J. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e32833b558c · Cited by 101
Lam, C. S. P., & Brutsaert, D. L. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.08.004 · Cited by 101
Self-citationCoronary endothelial dysfunction in patients with acute-onset idiopathic dilated cardiomyopathy
Mathier, M. A., Rose, G. A., Fifer, M. A., Miyamoto, M. I., Dinsmore, R. E., Castaño, H. H. G., Dec, G. W., Palacios, I. F., & Semigran, M. J. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00209-5 · Cited by 95
Soluble guanylate cyclase stimulation: an emerging option in pulmonary hypertension therapy
Ghofrani, H. A., & Grimminger, F. (2009) · European Respiratory Review · doi:10.1183/09059180.00011112 · Cited by 65
Cawley, S. M., Kolodziej, S. A., Ichinose, F., Brouckaert, P., Buys, E. S., & Bloch, K. D. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01273.2010 · Cited by 34
Ogunyankin, K. O., Liu, K., Lloyd‐Jones, D. M., Colangelo, L. A., & Gardin, J. M. (2011) · Echocardiography · doi:10.1111/j.1540-8175.2010.01290.x · Cited by 24
Ramos-Espiritu, L. S., Hess, K. C., Buck, J., & Levin, L. R. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.184135 · Cited by 7
Cited by
Antlanger, M., Aschauer, S., Kopecky, C., Hecking, M., Kovarik, J. J., Werzowa, J., Mascherbauer, J., Genser, B., Säemann, M. D., & Bonderman, D. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000473868 · Cited by 2,808
Self-citationPhenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap
Shah, S. J., Kitzman, D. W., Borlaug, B. A., van Heerebeek, L., Zile, M. R., Kass, D. A., & Paulus, W. J. (2016) · Circulation · doi:10.1161/circulationaha.116.021884 · Cited by 1,003
Nitric oxide signalling in cardiovascular health and disease
Farah, C., Michel, L. Y. M., & Balligand, J.-L. (2018) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.224 · Cited by 779
Left ventricular heart failure and pulmonary hypertension
Rosenkranz, S., Gibbs, J. S. R., Wachter, R., De Marco, T., Vonk-Noordegraaf, A., & Vachiéry, J.-L. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv512 · Cited by 692
Self-citationGorter, T. M., van Veldhuisen, D. J., Bauersachs, J., Borlaug, B. A., Celutkiene, J., Coats, A. J. S., Crespo-Leiro, M. G., Guazzi, M., Harjola, V.-P., Heymans, S., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1029 · Cited by 389
Self-citation
Metadata
- Authors
- Bonderman, D., Pretsch, I., Steringer-Mascherbauer, R., Jansa, P., Rosenkranz, S., Tufaro, C., Bojic, A., Lam, C. S. P., Frey, R., Ochan Kilama, M., Unger, S., Roessig, L., & Lang, I. M.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2014-11
- Volume
- 146
- Issue
- 5
- Pages
- 1274-1285
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W1984243104
- Cited by
- 260
- References
- 33
- FWCI
- 25.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.